Brexanolone tolerated in super-refractory status epilepticus
(HealthDay)—For patients with super-refractory status epilepticus (SRSE), brexanolone as adjunctive therapy is tolerated and associated with a high rate of third-line agent (TLA) weaning, according to a study published ...
Aug 9, 2017
0
0